MyAverix Finance
BR · Healthcare
Argen-X (ARGX)
Biotechnology
Argen-X (ARGX) is listed on BR in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $43.59B, P/E ratio is 36.23, net margin is 31.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ARGX
Argen-X (ARGX) — FAQ
What is Argen-X's market cap?
Argen-X (ARGX) has a reported market cap of $43.59B (data as of 2026-05-24).
What is ARGX's P/E ratio?
The price-to-earnings (P/E) ratio for Argen-X (ARGX) is 36.23 (data as of 2026-05-24).
Does Argen-X pay a dividend?
Dividend yield is not available in the current snapshot for Argen-X (ARGX). Check the MyAverix Finance app for the latest dividend data.
What sector is Argen-X in?
Argen-X (ARGX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ARGX listed on?
ARGX is listed on BR.
What is Argen-X's net margin?
Argen-X (ARGX) reports a net margin of 31.4% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.